C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank43
3Y CAGR+35.9%
5Y CAGR-16.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+35.9%/yr
vs -4.9%/yr prior
5Y CAGR
-16.3%/yr
Recent acceleration
Acceleration
+40.7pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $74.60M | +34.4% |
| 2024 | $55.50M | -56.2% |
| 2023 | $126.59M | +325.5% |
| 2022 | $29.75M | -60.9% |
| 2021 | $76.12M | -58.1% |
| 2020 | $181.73M | +100.7% |
| 2019 | $90.55M | +149.4% |
| 2018 | $36.31M | - |